World EPA Congress 2025

Panel on Innovative Pricing Models for Advanced Therapies at the World Evidence, Pricing and Access Congress in Amsterdam – Highlights from a Dynamic Discussion

On Thursday, 6th March, from 12:40 to 13:20, the panel discussion "Innovative Pricing Models for Advanced Therapies: Overcoming National Fragmentation and Facilitating Cross-Border Access" took place at the World Evidence, Pricing and Access Congress in Amsterdam (Rare Diseases G105).

The session brought together leading voices from across Europe—including industry representatives, policymakers, payers, and HTA experts—to examine pathways for sustainable pricing and improved access to advanced therapy medicinal products (ATMPs).

Key topics addressed included:
🔹 Regulatory and reimbursement challenges at the national level
🔹 Strategies to support patient mobility and cross-border access
🔹 Collaborative approaches emerging from EU consortia such as T2EVOLVE, JOIN4ATMP, HI-PRIX HORIZON, and ASCERTAIN

Moderated by Oriana Ciani (SDA Bocconi School of Management, HI-PRIX HORIZON), the panel featured expert contributions from:
✔ Ilaria Villa (CEO, Fondazione Telethon, JOIN4ATMP)
✔ Carin Uyl-de Groot (Director, institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam; ASCERTAIN, T2EVOLVE)

The session offered a timely and constructive exchange on the future of pricing models for ATMPs in Europe—highlighting the importance of cross-national collaboration to overcome access barriers and ensure long-term sustainability.